Mineralys Therapeutics, Inc.
MLYS
$25.02
-$0.71-2.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 231.32% | 125.20% | 4.44% | 1.32% | -16.22% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -33.68% | 49.38% | 50.35% | 39.08% | -42.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 222.08% | 124.03% | 5.43% | 2.22% | -17.56% |
|
|
|||||
| Total Current Assets | 222.08% | 124.03% | 5.43% | 2.22% | -17.56% |
| Net Property, Plant & Equipment | -28.30% | -89.86% | -47.62% | -25.49% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -23.45% | -68.14% | -3.56% | 4.75% | 878.43% |
| Total Assets | 221.42% | 123.65% | 5.41% | 2.22% | -18.17% |
|
|
|||||
| Total Accounts Payable | 321.09% | -63.91% | 85.35% | -91.25% | -20.30% |
| Total Accrued Expenses | -7.56% | -20.61% | -28.78% | -12.92% | 43.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.19% | -24.91% | -21.92% | -30.30% | 39.73% |
|
|
|||||
| Total Current Liabilities | 3.19% | -24.91% | -21.92% | -30.30% | 39.73% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.19% | -24.91% | -21.92% | -30.30% | 39.73% |
|
|
|||||
| Common Stock & APIC | 123.56% | 104.15% | 43.96% | 41.72% | 34.96% |
| Retained Earnings | -51.12% | -67.58% | -96.73% | -120.67% | -142.58% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 238.13% | 143.29% | 8.09% | 4.12% | -20.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 238.13% | 143.29% | 8.09% | 4.12% | -20.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 238.13% | 143.29% | 8.09% | 4.12% | -20.69% |
|
|
|||||